Live Webcast: Wednesday, October 3, 2012
10:00 am EDT (Eastern Daylight Time)
Register Free at www.pharmtech.com/oralsolid
EVENT OVERVIEW
Pediatric drug products require specialized consideration in formulation development. This niche field has gained attention among regulatory authorities in Europe, North America, and beyond, thereby providing new perspectives on and expectations of pharmaceutical drug formulators. Unique considerations must be addressed when formulating for this population, including excipient selection, dosage form, and patient compliance.
This webinar will provide an overview of current strategies and opportunities in pediatric oral solid dosage formulation development as well as insight into potential delivery options for this niche group. Technical advances and global regulatory expectations will be discussed, as will specifics in multidose and controlled release oral solid dose presentations. Strategies to improve compliance through palatability, inclusion of color for brand recognition, and single daily dose vs. multiple daily dose products will be presented.
Key Learning Objectives
- Insights into the unique regulatory considerations to be addressed when formulating for the pediatric population
- Opportunities to improve patient compliance by formulating specifically to meet niche group needs.
- Unique considerations, including excipient selection, dosage form and patient compliance.
Who Should Attend
Pharmaceutical development, formulation, manufacturing, and regulatory professionals involved in creating, manufacturing, or marketing oral solid dosage products for pediatric populations across the globe.
|
Presenters
|
||||||||
|
0 comments:
Post a Comment